Related Experiment Video

Updated: May 29, 2025

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

9.4K

Breaking barriers: Smart vaccine platforms for cancer immunomodulation

Mohammad Mahmoudi Gomari1, Taha Ghantabpour2, Nima Pourgholam3

  • 1Department of Medical Biotechnology, Faculty of Allied Medicine, Iran University of Medical Sciences, Tehran, Iran.

Cancer Communications (London, England)
|February 4, 2025
PubMed

Insights

Smart vaccine platforms (SVPs) offer innovative cancer vaccine solutions by integrating messenger RNA (mRNA) delivery with advanced functionalization. These smart vaccine platforms aim to overcome challenges and improve cancer treatment efficacy.

Area of Science:

  • Oncology
  • Immunology
  • Biotechnology

Background:

  • Current cancer therapies frequently fail to eliminate all malignant cells, necessitating novel treatment strategies.
  • Cancer vaccines hold significant therapeutic promise by harnessing the immune system to target cancer cells.
  • Key challenges in cancer vaccine development include poor stability, insufficient immune activation, and the immunosuppressive tumor microenvironment.

Purpose of the Study:

  • To review recent advancements in smart vaccine platforms (SVPs) for cancer therapy.
  • To explore how innovative technologies address existing cancer vaccine limitations.
  • To discuss the opportunities and challenges associated with SVP development in cancer treatment.

Main Methods:

  • Integration of nanotechnology, exosome engineering, and neoantigen design for SVP development.
  • Application of click chemistry for enhanced messenger RNA (mRNA) antigen encapsulation and targeted delivery.
  • Development of protective carriers for mRNA with functionalization strategies for optimized delivery.

Main Results:

  • Emergence of SVPs that combine mRNA delivery with advanced functionalization strategies.
  • Click chemistry improves mRNA antigen encapsulation and precise delivery to target cells.
  • SVPs show potential to overcome limitations of traditional cancer vaccines.

Conclusions:

  • Smart vaccine platforms represent a promising frontier in cancer vaccine technology.
  • Continued innovation in areas like click chemistry and nanotechnology is crucial for advancing SVPs.
  • Addressing challenges in stability, immune response, and tumor microenvironment is key for clinical translation of SVPs.
Keywords:
cancerclick chemistrymRNA vaccinessmart vaccine platformstargeted delivery

More Related Videos

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine09:15

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

3.3K
A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy09:56

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

Published on: February 21, 2025

434

Related Concept Videos

Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
329
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
464
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.4K
Vaccinations01:51

Vaccinations

Overview
43.9K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.5K